{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T08:33:39Z","timestamp":1719563619101},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jash.2007.01.006","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T11:19:14Z","timestamp":1175080754000},"page":"120-134","source":"Crossref","is-referenced-by-count":6,"title":["Understanding essential hypertension from the perspective of the cardiometabolic syndrome"],"prefix":"10.1016","volume":"1","author":[{"given":"Poorna R.","family":"Karuparthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preethi","family":"Yerram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Lastra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2007.01.006_bib1","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.006_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988\u20132000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.006_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1098-3597(01)90026-2","article-title":"Update on the cardiometabolic syndrome","volume":"4","author":"Sowers","year":"2001","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.jash.2007.01.006_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.006_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.1993.00410050036006","article-title":"Blood pressure, systolic and diastolic, and cardiovascular risks: US population data","volume":"153","author":"Stamler","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib6","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.01.006_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease, part 1; prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.01.006_bib8","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.006_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of metabolic syndrome among adults","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.006_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archinte.164.19.2126","article-title":"The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem","volume":"164","author":"Wang","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib11","doi-asserted-by":"crossref","first-page":"H1597","DOI":"10.1152\/ajpheart.00026.2004","article-title":"Insulin resistance and hypertension","volume":"286","author":"Sowers","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"suppl 1","key":"10.1016\/j.jash.2007.01.006_bib12","first-page":"S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2007.01.006_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.006_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1210\/jc.86.2.713","article-title":"Insulin resistance and cardiovascular disease","volume":"86","author":"McFarlane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2007.01.006_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.HYP.37.2.433","article-title":"Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats","volume":"37","author":"Cheng","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0895-7061(94)00160-D","article-title":"Increased basal arterial smooth muscle glucose transport in the Zucker rat","volume":"8","author":"Standley","year":"1995","journal-title":"Am J Hypertens"},{"issue":"suppl 1","key":"10.1016\/j.jash.2007.01.006_bib17","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0895-7061(99)00252-6","article-title":"Risk stratification in hypertension: new insights from the Framingham Study","volume":"13","author":"Kannel","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Banting Lecture 1988: role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jash.2007.01.006_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.0197-3118.2006.05454.x","article-title":"Introduction: organ involvement in the cardiometabolic syndrome","volume":"1","author":"Hayden","year":"2006","journal-title":"J CardioMetabolic Syndr"},{"key":"10.1016\/j.jash.2007.01.006_bib20","first-page":"SR35","article-title":"Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure","volume":"9","author":"Hayden","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jash.2007.01.006_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association Conference on Scientific Issues Related to Definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.006_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jash.2007.01.006_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"suppl 4","key":"10.1016\/j.jash.2007.01.006_bib24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sj.ijo.0802210","article-title":"Adipose tissue: a mediator of cardiovascular risk","volume":"26","author":"Sharma","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.jash.2007.01.006_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1385\/ENDO:13:2:155","article-title":"Metabolic complication of obesity","volume":"13","author":"Scott","year":"2000","journal-title":"Endocrine"},{"key":"10.1016\/j.jash.2007.01.006_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2796.1998.00301.x","article-title":"Individuals with high total cholesterol\/HDL cholesterol ratios are insulin resistant","volume":"243","author":"Jeppesen","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.metabol.2004.10.005","article-title":"Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia","volume":"54","author":"Kern","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jash.2007.01.006_bib28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1172\/JCI112925","article-title":"Insulin stimulates volume absorption in the rabbit proximal convoluted tubule","volume":"79","author":"Baum","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2007.01.006_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI107996","article-title":"The effect of insulin in renal handling of sodium, potassium, calcium, and phosphate in man","volume":"55","author":"DeFronzo","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2007.01.006_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1557-0843(06)80005-9","article-title":"Hypertension in type 2 diabetes mellitus","volume":"1","author":"Hayden","year":"2006","journal-title":"Insulin"},{"key":"10.1016\/j.jash.2007.01.006_bib31","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.98.22.2453","article-title":"Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms","volume":"98","author":"Nickenig","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.006_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.HYP.0000036448.44066.53","article-title":"Angiotensin blockade prevents type 2 diabetes by formation of fat cells","volume":"40","author":"Sharma","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib33","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.amjmed.2006.01.010","article-title":"The obese patient with diabetes mellitus: from research targets to treatment options","volume":"119","author":"Sharma","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jash.2007.01.006_bib34","first-page":"233","article-title":"Endothelial function and dysfunction","volume":"23","author":"Hanspeter","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib35","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000069826.36125.B4","article-title":"Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases","volume":"107","author":"Safar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.006_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1524-6175.2005.04617.x","article-title":"Hypertension and the cardiometabolic syndrome","volume":"7","author":"Lastra","year":"2005","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000109321.76818.14","article-title":"Heterogeneity of cardiorenal characteristics in normotensive subjects","volume":"43","author":"Fesler","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/01.HYP.25.1.98","article-title":"Myocardial remodeling in hypertensive Ren-2 transgenic rats","volume":"25","author":"Villarreal","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1559-4564.2006.05626.x","article-title":"Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome","volume":"1","author":"Hayden","year":"2006","journal-title":"J Cardiometabolic Syndr"},{"key":"10.1016\/j.jash.2007.01.006_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1559-4564.2006.05625.x","article-title":"Microalbuminuria and proximal tubule remodeling in the cardiometabolic syndrome","volume":"1","author":"Hayden","year":"2006","journal-title":"J Cardiometabolic Syndr"},{"key":"10.1016\/j.jash.2007.01.006_bib41","first-page":"533","article-title":"Detecting microalbuminuria and taking action in the cardiometabolic syndrome and type 2 diabetes mellitus","volume":"103","author":"Hayden","year":"2006","journal-title":"Mo Med"},{"key":"10.1016\/j.jash.2007.01.006_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000088810","article-title":"Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte","volume":"25","author":"Hayden","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jash.2007.01.006_bib43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1152\/ajprenal.00252.2006","article-title":"Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat","volume":"292","author":"Hayden","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jash.2007.01.006_bib44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1524-6175.2005.04769.x","article-title":"Expanding the definition and classification of hypertension (on behalf of the Hypertension Writing Group)","volume":"7","author":"Giles","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2007.01.006_bib45","doi-asserted-by":"crossref","first-page":"F442","DOI":"10.1152\/ajprenal.00247.2003","article-title":"Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective","volume":"286","author":"Lane","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jash.2007.01.006_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"104","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00041552-200401000-00012","article-title":"New insights into significance of microalbuminuria","volume":"13","author":"Maclsaac","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib48","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and non cardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.006_bib49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2007.01.006_bib50","first-page":"1829","article-title":"Utility of ambulatory blood pressure recording in therapeutic trials of antihypertensive drugs","volume":"115","author":"Rion","year":"1985","journal-title":"Schweiz Med Wochenscr"},{"key":"10.1016\/j.jash.2007.01.006_bib51","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/00004872-200018110-00012","article-title":"Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk","volume":"18","author":"Kailasam","year":"2000","journal-title":"J Hypertens"},{"issue":"suppl 1","key":"10.1016\/j.jash.2007.01.006_bib52","first-page":"S80","article-title":"Treatment of hypertension in adults with diabetes","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"10.1016\/j.jash.2007.01.006_bib53","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.006_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.HYP.37.1.12","article-title":"Baseline characteristics and elderly blood pressure control in the CONVINCE Trial","volume":"37","author":"Black","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2007.01.006_bib56","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.amjhyper.2003.07.009","article-title":"Recommendations for special populations: diabetes mellitus and the metabolic syndrome","volume":"16","author":"Sowers","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archinte.1997.00440270105009","article-title":"Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The trials of hypertension prevention, phase II","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.HYP.35.2.544","article-title":"Long term effects of weight loss and dietary sodium reduction on incidence of hypertension","volume":"35","author":"He","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced sodium and the Dietary Approaches to Stop Hypertension (DASH) diet","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.006_bib60","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.006_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","article-title":"Thiazide diuretics, potassium, and the development of diabetes: a quantitative review","volume":"48","author":"Zillich","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib62","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest","volume":"330","author":"Siscovick","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.006_bib63","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"Braunwald","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2007.01.006_bib64","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.006_bib65","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1503\/cmaj.060110","article-title":"Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis","volume":"174","author":"Khan","year":"2006","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jash.2007.01.006_bib66","unstructured":"The National Collaborating Centre for Chronic Conditions. Hypertension: management of hypertension in adults in primary care (partial update of NICE Clinical Guideline 18, published August 2004). June 2006. Accessed from http:\/\/www.nice.org.uk\/full guideline on October 16, 2006."},{"key":"10.1016\/j.jash.2007.01.006_bib67","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.HYP.38.3.705","article-title":"Treatment of obesity hypertension and diabetes syndrome","volume":"38","author":"Zanella","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib68","doi-asserted-by":"crossref","first-page":"49B","DOI":"10.1016\/j.amjcard.2004.01.026","article-title":"Advantages of a third-generation beta-blocker in patients with diabetes mellitus","volume":"93","author":"Bell","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2007.01.006_bib69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril on cardiovascular events in high-risk patients","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.006_bib70","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.01.006_bib71","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00004872-200403000-00029","article-title":"Development of diabetes is retarded by ACE inhibition in hypertensive patients \u2014 a subanalysis of the Captopril Prevention Project (CAPPP)","volume":"22","author":"Niklason","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib72","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2337\/diacare.24.12.2091","article-title":"Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic\/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project","volume":"24","author":"Niskanen","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2007.01.006_bib73","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.006_bib74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib75","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib76","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction (LIFE) in hypertension study: a randomized trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.01.006_bib77","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.01.006_bib78","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.01.006_bib79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ecl.2004.11.007","article-title":"Hypertension management in type 2 diabetes mellitus: recommendations of the Joint National Committee VII","volume":"34","author":"Whaley-Connell","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jash.2007.01.006_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1098-3597(04)80078-4","article-title":"Calcium channel blockers in the treatment of hypertension and prevention of cardiovascular disease: results from major clinical trials","volume":"6","author":"Black","year":"2004","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.jash.2007.01.006_bib81","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.157.21.2413","article-title":"National High Blood Pressure Education Program","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2007.01.006_bib82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0895-7061(95)00396-7","article-title":"Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men: relationship to changes in skeletal muscle blood flow","volume":"9","author":"Anderson","year":"1996","journal-title":"Am J of Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib83","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/0895-7061(96)00290-7","article-title":"Hyperinsulinemia, insulin resistance, and the treatment of hypertension","volume":"9","author":"Lithell","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib84","first-page":"239","article-title":"Diuretic versus \u03b1-blocker as first-step antihypertensive therapy","volume":"2","year":"2003","journal-title":"Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"},{"key":"10.1016\/j.jash.2007.01.006_bib85","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.0000156466.02908.ED","article-title":"Aliskerin, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients","volume":"111","author":"Gradman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.006_bib86","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.HYP.0000101688.17370.87","article-title":"Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren","volume":"42","author":"Stanton","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.01.006_bib87","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11906-006-0090-z","article-title":"New drugs for hypertension: what do they offer?","volume":"8","author":"Gradman","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jash.2007.01.006_bib88","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjhyper.2005.12.017","article-title":"Actions of peroxisome proliferators\u2014activated receptors-agonists explaining a possible blood pressure-lowering effect","volume":"19","author":"Sarafidis","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.01.006_bib89","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.01.006_bib90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/rp.56.1.265","article-title":"Insulin resistance and its treatment by thiazolidinediones","volume":"56","author":"Lebovitz","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.jash.2007.01.006_bib91","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/01.HYP.0000136909.14661.7c","article-title":"Trial of Preventive Hypertension (TROPHY): design and 2-year progress report","volume":"44","author":"Kaplan","year":"2004","journal-title":"Hypertension"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171107000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171107000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T14:53:57Z","timestamp":1546959237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171107000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1933171107000186"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2007.01.006","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}